GADD45A Human Pre-designed siRNA Set A contains three designed siRNAs for GADD45A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GADD45B Human Pre-designed siRNA Set A contains three designed siRNAs for GADD45B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GADD45G Human Pre-designed siRNA Set A contains three designed siRNAs for GADD45G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GADL1 Human Pre-designed siRNA Set A contains three designed siRNAs for GADL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gadodiamide (Standard) is the analytical standard of Gadodiamide. This product is intended for research and analytical applications. Gadodiamide (Omniscan) is a gadolinium-containing contrast agent used in medical imaging.

GAGE1 Human Pre-designed siRNA Set A contains three designed siRNAs for GAGE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GAGE8 Human Pre-designed siRNA Set A contains three designed siRNAs for GAGE8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GAK Human Pre-designed siRNA Set A contains three designed siRNAs for GAK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gak Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gak gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gak Rat Pre-designed siRNA Set A contains three designed siRNAs for Gak gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GAL Human Pre-designed siRNA Set A contains three designed siRNAs for GAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GAL3ST1 Human Pre-designed siRNA Set A contains three designed siRNAs for GAL3ST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GAL3ST4 Human Pre-designed siRNA Set A contains three designed siRNAs for GAL3ST4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Galacto-dapagliflozin is a selective inhibitor for hSGLT2 with Ki of 25 nM[1].

Galbinic acid (α-Acetylsalazinic acid), a lichen acid, shows antibacterial activities against the Gram-positive bacteria B. cereus, B. subtilis, and S. aureus (MICs=62.5, 62.5, 250 μg/ml, respectively). Galbinic acid inhibits the Gram-negative bacterium E. coli (MIC=125 μg/ml)[1][2].

GALC Human Pre-designed siRNA Set A contains three designed siRNAs for GALC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALE Human Pre-designed siRNA Set A contains three designed siRNAs for GALE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Galectin-3-IN-3 (Compound 4) is an orally active and selective inhibitor of Gal-3, with IC50 values of 11 nM and 84 nM against mGal-3 and hGal-3 respectively[1].

Galectin-3-IN-4 (compound 5) is a carboxamide analog. Galectin-3-IN-4 is a potent, selective, and orally bioavailable inhibitor of human and mouse galectin-3, with IC50 values of 21 and 167 nM for hGal-3 and mGal-3, respectively. Galectin-3-IN-4 has IC50 values of 1580 and 2750 nM for hGal-1 and hGal-9, respectively[1].

Galectin-4-IN-2 (compound 12) is an inhibitor of galectin 4C with a galectin dissociation constant of 1.6 mM[1].

Galectin-4-IN-3 (Compound 11) is a Galectin 4C inhibitor, with a Kd of 160 μM[1].

Galectin-8-IN-2 (Compound 10) is a galectin-8N inhibitor[1].

GALK1 Human Pre-designed siRNA Set A contains three designed siRNAs for GALK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALK2 Human Pre-designed siRNA Set A contains three designed siRNAs for GALK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].

Gallinamide A TFA is a linearly depositing peptide and a potent inhibitor of cathepsin L (CatL) (IC50: 17.6 pM). Gallinamide A TFA inhibits SARS-CoV-2 infection by inhibiting CatL (EC50: 28 nM). Gallinamide A TFA also inhibits Plasmodium falciparum (IC50: 50 nM)[1][2].

GALM Human Pre-designed siRNA Set A contains three designed siRNAs for GALM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNS Human Pre-designed siRNA Set A contains three designed siRNAs for GALNS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT1 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT10 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT11 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT12 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT13 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT14 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT15 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT17 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT18 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT2 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GALNT3 Human Pre-designed siRNA Set A contains three designed siRNAs for GALNT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.